ABT vs DXCM: Fair Value Comparison
ABT's model fair value sits 22.6% above its current price; DXCM's model fair value sits 21.1% below its current price. Of the two, ABT trades further below its model estimate. Model estimates under stated assumptions. Data as of 2026-10-22.
| ABT | DXCM | |
|---|---|---|
| Price | $102.48 | $78.33 |
| Model fair value (multi-method blend) | $125.59 | $61.79 |
| Model fair value differential | +22.6% | -21.1% |
| Methods with a model value above price | 7 of 11 | 9 of 9 |
| Fundamental strength | B | A- |
| Next earnings report | — | 2026-10-29 |
More comparisons
ABT vs MDT · ABT vs SYK · ABT vs BSX · ABT vs EW · MDT vs DXCM · SYK vs DXCM · BSX vs DXCM · EW vs DXCM · All Medical Devices stocks · Compare any two stocks